PharPoint Research

 
  • Increase font size
  • Default font size
  • Decrease font size
Press Releases

PharPoint Research Expands Wilmington, NC Office

Friday, 25 June 2010 09:59
 E-mail | Print | PDF 

Chapel Hill, NC, June 25, 2010 - PharPoint Research, Inc., a drug development service company providing biostatistics and data management services to the pharmaceutical and biotechnology industries, announces that it recently leased additional space near the current Wilmington, NC office, allowing for expansion as the business continues to quickly grow.

 

Cellceutix Signs Agreements for Kevetrin(TM) Phase 1 Support

Monday, 24 May 2010 17:48
 E-mail | Print | PDF 

BEVERLY, MA - May 24, 2010 - Cellceutix Corporation (OTCBB: CTIX), a bio-pharmaceutical company that develops small molecules to treat cancer, autism and inflammatory disease, today announced that it has concluded agreements with PharPoint Reasearch for Phase 1 data management and statistical analysis and with Medical Research Consulting Services for Phase 1 clinical monitoring. The terms of the agreements were not disclosed. These agreements provide the basic resources necessary to conduct the Phase 1 study of the Company's cancer compound, Kevetrin.

 

PharPoint Research Incorporates Medrio EDC Software into its Data Management Offerings

Monday, 08 March 2010 13:45
 E-mail | Print | PDF 

Chapel Hill, NC, March 8, 2010 − PharPoint Research, Inc., a drug development service company providing biostatistics and data management services to the pharmaceutical and biotechnology industries, announces that it has incorporated Medrio’s EDC technology platform into its growing suite of data management applications.